Downgrades Buy Neutral X

PACB Pacific Biosciences

UBS

Resumed Buy X

PACB Pacific Biosciences

Jefferies

$4

Downgrades Overweight Neutral X

PACB Pacific Biosciences

JP Morgan

Downgrades Buy Neutral X

PACB Pacific Biosciences

Goldman

$7 $2.50

Initiated Neutral X

PACB Pacific Biosciences

Guggenheim

Initiated Overweight X

PACB Pacific Biosciences

Stephens

$11

Initiated Peer Perform X

PACB Pacific Biosciences

Wolfe Research

Upgrades Neutral Buy X

PACB Pacific Biosciences

UBS

$13 $10

Upgrades Neutral Overweight X

PACB Pacific Biosciences

Cantor Fitzgerald

$11

Initiated Outperform X

PACB Pacific Biosciences

Bernstein

$11

Resumed Overweight X

PACB Pacific Biosciences

JP Morgan

$13

Initiated Buy X

PACB Pacific Biosciences

Goldman

$17

Initiated Equal Weight X

PACB Pacific Biosciences

Barclays

$14

Upgrades Mkt Perform Outperform X

PACB Pacific Biosciences

TD Cowen

$13 $15

Initiated Neutral X

PACB Pacific Biosciences

UBS

$13

Downgrades Overweight Neutral X

PACB Pacific Biosciences

Cantor Fitzgerald

$12

Initiated Sector Outperform X

PACB Pacific Biosciences

Scotiabank

$12

Resumed Overweight X

PACB Pacific Biosciences

Cantor Fitzgerald

$62 $31

Resumed Neutral X

PACB Pacific Biosciences

Piper Sandler

$20

Resumed Market Perform X

PACB Pacific Biosciences

Cowen

$30

Upgrades Neutral Overweight X

PACB Pacific Biosciences

Piper Sandler

$20 $52

Downgrades Overweight Eq-Weight X

PACB Pacific Biosciences

Stephens

$4.50 $8

Initiated Outperform X

PACB Pacific Biosciences

Cowen

PACB  Pacific Biosciences of California, Inc.

Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Its SMRT technology enables the observation of deoxyribonucleic acid (DNA) synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. Its phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. The PacBio RS II and Sequel instruments include optics, automated liquid handling, a touchscreen control interface and computational hardware and software.